Balyasny Asset Management’s Healthcare Capital Corp. Class A common stock HCCC Stock Holding History

Balyasny Asset Management’s Portfolio HCCC Stock Details HCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-150,000	Closed	-$1.48M	–	3050
2021 Q4	$1.48M	Hold	150,000	–	–	0.01%	1315
2021 Q3	$1.48M	Hold	150,000	–	–	0.01%	1213
2021 Q2	$1.45M	Hold	150,000	–	–	0.01%	1147
2021 Q1	$1.45M	Buy	+150,000	New	+$1.46M	0.01%	1151

Balyasny Asset Management's HCCC Position: Q1 2022 in Review

Balyasny Asset Management sold out of Healthcare Capital Corp. Class A common stock (HCCC) in Q1 2022, closing a stake of 150,000 shares — an estimated $1.48M sold.

Balyasny Asset Management first reported a position in HCCC in Q1 2021 and held it in 4 quarters. The position peaked at $1.48M in Q4 2021. 0 funds tracked by Wall St. Rank hold HCCC as of Q1 2022.

Balyasny Asset Management reported no remaining Healthcare Capital Corp. Class A common stock position as of Q1 2022 after selling out during the quarter.
Balyasny Asset Management sold 150,000 Healthcare Capital Corp. Class A common stock shares in Q1 2022, an estimated $1.48M.
Balyasny Asset Management first reported a position in Healthcare Capital Corp. Class A common stock in Q1 2021 and held it in 4 quarters.
Balyasny Asset Management's Healthcare Capital Corp. Class A common stock position peaked at $1.48M in Q4 2021.
0 funds tracked by Wall St. Rank held Healthcare Capital Corp. Class A common stock as of Q1 2022.

Based on Balyasny Asset Management's 13F filing for Q1 2022, filed 16 May 2022.